Raloxifene 60 mg

Dragon Pharma Raloxifene: The Advanced SERM for Reversing Existing Gynecomastia

For bodybuilders and athletes in the USA, the development of gynecomastia—the formation of glandular breast tissue—is one of the most dreaded side effects of anabolic steroid use. While SERMs like Nolvadex are excellent for prevention, Dragon Pharma Raloxifene represents a more advanced and targeted approach for treating existing, established gyno. As a second-generation Selective Estrogen Receptor Modulator (SERM), Raloxifene offers a superior tissue selectivity profile, making it potentially more effective and better tolerated for the specific task of reducing breast tissue that has already begun to form. It is the go-to choice for those seeking a powerful pharmacological solution to reverse gynecomastia without surgery.

Effects of Raloxifene

Raloxifene works by selectively binding to estrogen receptors throughout the body. Its key advantage lies in its tissue-specific activity: it acts as a potent antagonist in breast and uterine tissue, while acting as an agonist in bone. This refined mechanism provides distinct benefits for bodybuilders dealing with gynecomastia:

• Superior Reduction of Established Gynecomastia: Raloxifene is clinically recognized for its potent anti-estrogenic effects in breast tissue. It is particularly effective at shrinking existing glandular tissue, not just preventing its initial formation. Many users report Raloxifene is more effective than Nolvadex for reversing gyno that has progressed beyond simple puffiness into palpable lumps.
• Bone Density Preservation: Unlike other SERMs, Raloxifene has estrogenic effects on bone, helping to maintain and even increase bone mineral density. This is a valuable side benefit for long-term health, especially for athletes who may undergo periods of low estrogen.
• Favorable Lipid Profile Impact: Raloxifene generally has a positive effect on cholesterol, typically lowering total and LDL (bad) cholesterol without negatively impacting HDL (good) cholesterol.
• Uterine Safety: For the male target audience, this is not a direct benefit, but it highlights its clean profile. Unlike Nolvadex which can have stimulatory effects on the uterus, Raloxifene is neutral, indicating a more targeted anti-estrogenic action where it's needed.

As detailed by the National Library of Medicine, Raloxifene is a second-generation SERM with high affinity for estrogen receptors and is approved for use in reducing the risk of invasive breast cancer, underscoring its potency in breast tissue.

Proper Dosage and Administration for Gynecomastia

Raloxifene dosing for gynecomastia is focused on a relatively short-term, therapeutic protocol aimed at reducing existing tissue.

• Standard Gyno Reversal Protocol: 60mg taken once daily. This is the standard, well-tolerated dose used in clinical settings for breast tissue reduction and is the recommended starting point for treating steroid-induced gynecomastia.
• Aggressive/Maximum Dose Protocol: 60mg taken twice daily (total 120mg). This higher dose may be employed for severe or stubborn cases of gynecomastia that do not respond to the standard 60mg/day after 2-3 weeks. This should be considered a short-term, intensive therapy due to the increased load on the liver and potential for side effects.
• Mild/Preventative Dose (On-Cycle): While not its primary use, 30mg daily (half a tablet) can be used on-cycle by individuals extremely prone to gynecomastia as a preventative measure, though Nolvadex is more common for this purpose.

Duration of Treatment: A typical course of Raloxifene for gyno reversal lasts 4 to 8 weeks. Significant improvement is often seen within the first 2-4 weeks. If no improvement is seen after 8 weeks, it is unlikely to be effective for that particular case of gyno. The Dragon Pharma 60mg tablet is perfectly dosed for this application.

Using Raloxifene in Your Cycle and Post-Cycle

Raloxifene's primary role is as a therapeutic agent for existing gynecomastia, but it can be strategically used during different phases.

On-Cycle Gyno Reversal: This is its most powerful application. If you develop gynecomastia during a cycle, you can begin Raloxifene at 60mg/day without stopping your cycle. It is crucial to also address the root cause—high estrogen—by implementing or adjusting an Aromatase Inhibitor like Aromasin or Arimidex.

Post-Cycle Gyno Reversal: Gyno can sometimes appear or worsen during PCT due to hormonal fluctuations. Raloxifene can be safely incorporated into your PCT stack. It will not interfere with the HPTA-stimulating effects of Clomid or Enclomiphene and will provide targeted protection and reversal for breast tissue.

Sample Treatment Stacks with Dragon Pharma Products:

• Aggressive On-Cycle Gyno Attack: For gyno that appears during a heavy testosterone cycle (e.g., Testabol 400), run Raloxifene 60mg/day + an AI like Aromasin at 12.5mg EOD. This combination attacks the problem from two angles: reducing systemic estrogen and blocking its receptors in breast tissue.
• PCT Gyno Management: If you notice gyno flare-ups during PCT, add Raloxifene 60mg/day to your standard PCT of Enclomiphene and Nolvadex. Some users even substitute Raloxifene for Nolvadex in this scenario for its potentially superior gyno-reversal effects.
• Standalone Gyno Treatment (Off-Cycle): For pre-existing or persistent gyno, a cycle of Raloxifene at 60mg/day for 6-8 weeks can be run on its own, often with excellent results.

Synergistic Dragon Pharma Products

For a comprehensive approach to managing gynecomastia and overall cycle health, consider these synergistic products:

• Aromatase Inhibitors (AIs): As mentioned, using an AI like Aromasin or Arimidex is critical when treating on-cycle gyno. It addresses the high estrogen levels that are fueling the tissue growth.
• Other SERMs for PCT: Enclomiphene or Clomid are essential for Post-Cycle Therapy to restart natural testosterone production. Raloxifene can be used alongside them for gyno control.
• Liver Support: Raloxifene is processed by the liver. For longer courses or higher doses, incorporating a liver support supplement is a prudent measure, especially if your cycle included oral steroids like Dianabol 20 or Anadrol Inj 50.
• Prolactin Control: If your cycle includes 19-nor compounds like Deca 500 or Trenbolone 200, ensure you have Caber on hand, as prolactin can also contribute to gyno.

Possible Side Effects and Management

Raloxifene is generally well-tolerated, especially for the short durations used for gyno reversal. However, as a systemic medication, side effects are possible.

• Hot Flashes: This is the most common side effect, caused by the alteration of estrogen signaling in the hypothalamus. These are usually mild and temporary, subsiding as the body adjusts.
• Leg Cramps and Muscle Pain: Some users report experiencing leg cramps or general muscle discomfort while using Raloxifene.
• Peripheral Edema (Swelling): Mild swelling in the hands, arms, legs, or feet can occur.
• Increased Risk of Blood Clots: Like other SERMs, Raloxifene carries a small increased risk of venous thromboembolism (blood clots). This risk is low in healthy, active individuals but should be considered, especially if you have a personal or family history of clotting disorders.
• Insomnia and Headaches: These are less common but have been reported by some users.
• Liver Enzyme Increases: As with many oral medications, Raloxifene can cause transient elevations in liver enzymes. This is typically not a concern for short-term use but underscores the importance of not exceeding recommended durations without a break.

The third-party lab verification for this Dragon Pharma Raloxifene confirms a dosage of 58.23mg per tablet, providing the assurance you need that you are using a high-quality, accurately dosed product for predictable and effective gynecomastia treatment.

Raloxifene Profile

Name: Raloxifene
Drug Class: Selective Estrogen Receptor Modulator (SERM)
Other common names and terms: Raloxifene Hydrochloride, Evista
Active Life: Approximately 28 hours
Detection Time: Several weeks
Chemical Structure: [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl]-[4-[2-(1-piperidinyl)ethoxy]phenyl]methanone
Common Doses: 60mg (taken orally once or twice daily for gyno reversal)
Blood pressure: No significant direct effect.
Acne: Not associated with causing acne.
Water retention: Can help reduce estrogen-related water retention.
Aromatisation: Does not aromatize.
Liver toxicity: Can be liver toxic with prolonged, high-dose use, but generally safe for short-term gyno therapy.
Decrease HPTA function: No, it does not suppress the HPTA.

Third Party Lab Test Results

2025-04-18

View Result

58.23 mg/tab

2024-01-04

View Result

54.15 mg/tab